Which of the following is a selective α1A receptor bloc- ker that affords symptomatic relief in benign
prostatic hypertrophy without producing significant fall in blood pressure
Which of the following is a selective α1A receptor bloc- ker that affords symptomatic relief in benign
prostatic hypertrophy without producing significant fall in blood pressure